Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 10/20 | 0.54 |
| ▸ | PPARA | Q07869 | 9/20 | 0.54 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1685912 | 0.91 | PPARG (0.51) | PPARGPPARAS1PR1NPC1RAB9A | |
| SCHEMBL27039060 | 0.84 | HIF1A (0.52) | PPARGPPARANPC1RAB9AMEN1 | |
| SCHEMBL2792516 | 0.84 | HIF1A (0.52) | PPARGPPARANPC1RAB9AMEN1 | |
| SCHEMBL5112727 | 0.84 | HIF1A (0.52) | PPARGPPARANPC1RAB9AMEN1 | |
| SCHEMBL26650820 | 0.84 | HIF1A (0.52) | PPARGPPARANPC1RAB9AMEN1 | |
| SCHEMBL2792522 | 0.84 | HIF1A (0.52) | PPARGPPARANPC1RAB9AMEN1 | |
| SCHEMBL28652083 | 0.84 | HIF1A (0.52) | PPARGPPARANPC1RAB9AMEN1 | |
| SCHEMBL7073241 | 0.82 | PPARG (0.42) | PPARGPPARANPC1RAB9AMEN1 | |
| SCHEMBL10441908 | 0.82 | CES2 (0.54) | MEN1KMT2AMAOBNPSR1 | |
| SCHEMBL7070313 | 0.81 | PPARG (0.41) | PPARGPPARANPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100273649-A1 | Fungicidal Mixtures III | BASF SE (DE) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273649-A1 | Fungicidal Mixtures III | CBR3, CBR1, NOX3 | PPARG 2657/4885PPARA 2647/4885S1PR1 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.